Literature DB >> 8035522

Low efficiency of the 5' nontranslated region of hepatitis A virus RNA in directing cap-independent translation in permissive monkey kidney cells.

L E Whetter1, S P Day, O Elroy-Stein, E A Brown, S M Lemon.   

Abstract

To characterize in vivo the translational control elements present in the 5' nontranslated region (5'NTR) of hepatitis A virus (HAV) RNA, we created an HAV-permissive monkey kidney cell line (BT7-H) that stably expresses T7 RNA polymerase and carries out cytoplasmic transcription of uncapped RNA from transfected DNA containing the T7 promoter. The presence of an internal ribosomal entry site (IRES) within the 5'NTR of HAV was confirmed by using BT7-H cells transcribing bicistronic RNAs in which the 5'NTR was placed within the intercistronic space, controlling translation of a downstream reporter protein (bacterial chloramphenicol acetyltransferase). However, translation directed by the 5'NTR in these bicistronic transcripts and in monocistronic T7 transcripts in which the HAV 5'NTR was placed upstream of the chloramphenicol acetyltransferase coding sequence was very inefficient compared with the translation of monocistronic transcripts containing either the IRES of encephalomyocarditis (EMC) virus or a short nonpicornavirus 5' nontranslated leader sequence. A large deletion within the HAV IRES (delta 355-532) eliminated IRES activity in bicistronic transcripts. In contrast, larger deletions within the IRES in monocistronic transcripts (delta 1-354, delta 1-532, delta 1-633, and delta 158-633) resulted in 4- to 14-fold increases in translation. In the latter case, this was most probably due to a shift from IRES-directed translation to translation initiation by 5'-end-dependent scanning. Translation of RNAs containing either the EMC virus IRES or the nonpicornavirus leader was significantly enhanced by cotransfection of the reporter constructs with pEP2A, which directs transcription of RNA containing the EMC virus IRES fused to the poliovirus 2Apro coding region. This 2Apro enhancement of cap-independent translation suggests a greater availability of limiting cellular translation factors following 2Apro-mediated cleavage of the p220 subunit of the eukaryotic initiation factor eIF-4F and subsequent shutdown of 5' cap-dependent translation. In contrast, pEP2A cotransfection resulted in severe inhibition of translation directed by the HAV IRES in either monocistronic or bicistronic transcripts. This inhibition was due to competition from the EMC virus IRES present in pEP-2A transcripts, as well as the expression of proteolytically active 2Apro. 2Apro-mediated suppression of HAV translation was not seen with transcripts containing large deletions in the HAV IRES (delta 158-633, delta 1-532, or delta 1-633). These data suggest that the HAV IRES may have a unique requirement for intact p220 or that it may be dependent on active expression of another cellular translation factor which is normally present in severely limiting quantities.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8035522      PMCID: PMC236470     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Translational enhancement of the poliovirus 5' noncoding region mediated by virus-encoded polypeptide 2A.

Authors:  S J Hambidge; P Sarnow
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

2.  Conserved tertiary structural elements in the 5' nontranslated region of cardiovirus, aphthovirus and hepatitis A virus RNAs.

Authors:  S Y Le; J H Chen; N Sonenberg; J V Maizel
Journal:  Nucleic Acids Res       Date:  1993-05-25       Impact factor: 16.971

3.  The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.

Authors:  C M Gorman; G T Merlino; M C Willingham; I Pastan; B H Howard
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

4.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

5.  Radioimmunofocus assay for quantitation of hepatitis A virus in cell cultures.

Authors:  S M Lemon; L N Binn; R H Marchwicki
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

6.  Mutations within the 5' nontranslated region of hepatitis A virus RNA which enhance replication in BS-C-1 cells.

Authors:  S P Day; P Murphy; E A Brown; S M Lemon
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

7.  Identification of the hepatitis A virus internal ribosome entry site: in vivo and in vitro analysis of bicistronic RNAs containing the HAV 5' noncoding region.

Authors:  M J Glass; X Y Jia; D F Summers
Journal:  Virology       Date:  1993-04       Impact factor: 3.616

8.  Identification of a trans-acting activity from liver that stimulates hepatitis A virus translation in vitro.

Authors:  M J Glass; D F Summers
Journal:  Virology       Date:  1993-04       Impact factor: 3.616

9.  La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate.

Authors:  K Meerovitch; Y V Svitkin; H S Lee; F Lejbkowicz; D J Kenan; E K Chan; V I Agol; J D Keene; N Sonenberg
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

10.  In vitro characterization of an internal ribosomal entry site (IRES) present within the 5' nontranslated region of hepatitis A virus RNA: comparison with the IRES of encephalomyocarditis virus.

Authors:  E A Brown; A J Zajac; S M Lemon
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

View more
  51 in total

Review 1.  Bridging IRES elements in mRNAs to the eukaryotic translation apparatus.

Authors:  Kerry D Fitzgerald; Bert L Semler
Journal:  Biochim Biophys Acta       Date:  2009-07-23

2.  Interaction of poly(rC) binding protein 2 with the 5' noncoding region of hepatitis A virus RNA and its effects on translation.

Authors:  J Graff; J Cha; L B Blyn; E Ehrenfeld
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

3.  Coding sequences enhance internal initiation of translation by hepatitis A virus RNA in vitro.

Authors:  J Graff; E Ehrenfeld
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Translation initiation in GB viruses A and C: evidence for internal ribosome entry and implications for genome organization.

Authors:  J N Simons; S M Desai; D E Schultz; S M Lemon; I K Mushahwar
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Cap-independent translation initiation in Xenopus oocytes.

Authors:  B D Keiper; R E Rhoads
Journal:  Nucleic Acids Res       Date:  1997-01-15       Impact factor: 16.971

6.  Characterization of recombinant hepatitis A virus genomes containing exogenous sequences at the 2A/2B junction.

Authors:  M R Beard; L Cohen; S M Lemon; A Martin
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

7.  Hepatitis A virus adaptation to cellular shutoff is driven by dynamic adjustments of codon usage and results in the selection of populations with altered capsids.

Authors:  M Isabel Costafreda; Francisco J Pérez-Rodriguez; Lucía D'Andrea; Susana Guix; Enric Ribes; Albert Bosch; Rosa M Pintó
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

8.  Fine-tuning translation kinetics selection as the driving force of codon usage bias in the hepatitis A virus capsid.

Authors:  Lluís Aragonès; Susana Guix; Enric Ribes; Albert Bosch; Rosa M Pintó
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

9.  A phylogenetically conserved stem-loop structure at the 5' border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation.

Authors:  M Honda; M R Beard; L H Ping; S M Lemon
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Hepatitis A virus (HAV) packaging size limit.

Authors:  Krishnamurthy Konduru; Siham M Nakamura; Gerardo G Kaplan
Journal:  Virol J       Date:  2009-11-18       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.